Not all high-risk prostate cancers are the same

Researchers have identified distinct subgroups of men with high-risk prostate cancer who experience different outcomes following treatment with a combination of high-dose radiotherapy and androgen-deprivation therapy, according to a new report in BMC Urology
Renal and Urology News